Xeljanz 63539-0016-02
Generic: Tofacitinib
- Manufacturer
- U.s. Pharmaceuticals
- Dosage Form
- Tablet, Film Coated
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- July 2, 2018
- Listing Expires
- December 31, 2027
- Application
- NDA203214
Need to source Xeljanz? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Tofacitinib Citrate | 10 mg/1 |
Drug Class
Janus Kinase Inhibitor [EPC]Janus Kinase Inhibitors [MoA]
Selected Package
63539-0016-02Selected60 TABLET, FILM COATED in 1 BOTTLE (63539-016-02)